Researchers showed that low levels of placental growth factor (PlGF) -- a protein that signals placental development -- are ...

A new blood test discovered by researchers at the University of Toronto Faculty of Medicine may be able to determine whether an individual is at risk for preterm birth.

Study highlights concerns about premature adoption of preeclampsia screening tests, emphasizing the need for clinical utility trials before widespread implementation.

A groundbreaking study reveals that a simple blood test measuring placental growth factor (PlGF) levels can help predict ...

A research team from Sinai Health and the University of Toronto has identified a way to determine which mothers are more ...

The prospective observational study was able to show that other factors, including weight, race or previous pregnancy ...

A research team from Sinai Health and the University of Toronto has identified a way to determine which mothers are more likely to deliver a baby ...

Johnson & Johnson said the U.S. rollout of the Varipulse pulsed field ablation platform is back on after an investigation found the devices operate as intended. Can artificial intelligence (AI) ...

The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.

Nora Rosenberg summarises the largest and most comprehensive study to date on metabolomic pathways to antenatal depression, birth outcomes and offspring development.

During the trophoblast-independent stage of uterine arterial remodeling, dNK cells surround SA and synthesize a series of soluble factors to induce EVT invasion and initiate destabilization of ...